1. Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA;
2. Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY;
3. Stanford University School of Medicine, Stanford, CA;
4. University of California, San Francisco, San Francisco, CA;
5. Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA;
6. Harvard Medcl School, Charlestown, MA;
7. GlaxoSmithKline, Collegeville, PA;
8. Calithera Biosciences Inc, South San Francisco, CA;
9. Department of Medicine, Dana-Farber/Harvard Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA;
10. Emory University, Atlanta, GA;
11. Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL;
12. Columbia University Medical Center, New York, NY;
13. Department of Investigational Cancer Therapeutics (Phase 1 Program), Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX;
14. Sarah Cannon Research Institute, Nashville, TN;